Citations

Clear

107 citation(s) found for "Scheithauer, Bernd".

Free Alpha Subunit of the Pituitary Glycoprotein Hormones: Measurement in Serum and Tissue of Patients with Pituitary Tumors
Preissner, Carol M., Klee, George G., Scheithauer, Bernd W., Abboud, Charles F.

Mayo Clinic

American Journal of Clinical Pathology | March 17, 2016 | Volume: 94 | Issue: 4 | Pages: 417-421

10.1093/ajcp/94.4.417 | PMID 1699408 Get It

The Neuropathology of Tuberous Sclerosis
Scheithauer, Bernd W.

Mayo Clinic

The Journal of Dermatology | April 10, 2015 | Volume: 19 | Issue: 11 | Pages: 897-903

10.1111/j.1346-8138.1992.tb03802.x | PMID 1293180 Get It

AbstractTuberous sclerosis, an autosomal dominant disorder associated with hamartomas in multiple organs, prominently affects the central nervous system; principle lesions include subependymal nodules and giant cell astrocytomas, white matter heterotopias, and cortical tubers. Histologic, immunocytochemical, and ultrastructural features of these processes suggest they have their basis in abnormal cell migration and differentiation. Aberrant expression of cystoskeletal proteins appears to be common to the multisystem hamartomas of this disorder and may, in part, underlie their pathogenesis.
Leptin and Leptin Receptor Expression in Normal and Neoplastic Human Pituitary: Evidence of a Regulatory Role for Leptin on Pituitary Cell Proliferation1
Jin, Long , Burguera, Bartolomé , Couce, Marta , Scheithauer, Bernd W., Lamsan, Jesse, Eberhardt, Norman L., Kulig, Elzbieta, Lloyd, Ricardo V.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | January 8, 2014 | Volume: 84 | Issue: 8 | Pages: 2903-2911

10.1210/jcem.84.8.5908 | PMID 10443698 Get It

Leptin is a circulating hormone secreted by adipose and a few other tissues. The leptin receptor consists of a single transmembrane-spanning polypeptide that is present as a long physiologically important form as well as in several short isoforms. Recent studies have suggested that the anterior pituitary may have a role in the regulatory effects of leptin in animal models. To test this possibility in human pituitaries, we examined the expression of leptin and OB-R in normal and neoplastic pituitaries, and the possible functions of leptin in the pituitary were also analyzed. Leptin was present in 20–25% of anterior pituitary cells and was expressed in most normal anterior pituitary cells, including ACTH (70% of ACTH cells), GH (21%), FSH (33%), LH (29%), TSH (32%), and folliculo-stellate cells (64%), but was colocalized with very few PRL cells (3%), as detected by double labeling immunohistochemistry with two different antileptin antibodies. In addition, leptin expression was detected by RT-PCR in some pituitary tumors, including ACTH (three of four), GH (one of four), null cells (two of four), and gonadotroph (one of four) tumors as well as in normal pituitary. Immunohistochemical staining showed greater immunoreactivity for leptin in normal pituitaries compared to adenomas. Treatment of an immortalized cultured anterior pituitary cell line, HP75, with leptin stimulated pancreastatin secretion in vitro. Leptin also inhibited cell growth in the human HP75 and in the rat pituitary GH3 cell lines. Both long (OB-Rb) and common (OB-Ra) forms of the leptin receptor messenger ribonucleic acid and leptin receptor protein were expressed in normal and neoplastic anterior pituitary cells. These findings show for the first time that leptin is expressed by most human anterior pituitary cell types and that there is decreased leptin protein immunoreactivity in pituitary adenomas compared to that in normal pituitary tissues. We also show that OB-Rb is widely expressed by normal and neoplastic anterior pituitary cells, implicating an autocrine/paracrine loop in the production and regulation of leptin in the pituitary.
Pituitary Stalk Lesions: The Mayo Clinic Experience
Lin, Eleanor , Guadalix, Sonsoles, Schwartz, Kara M., Scheithauer, Bernd W., Atkinson, John L. D., Turcu, Adina F. , Erickson, Bradley J. , Young, William F.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | March 27, 2013 | Volume: 98 | Issue: 5 | Pages: 1812-1818

10.1210/jc.2012-4171 | PMID 23533231 Get It

Adipose lesions of nerve: the need for a modified classification
Spinner, Robert J. , Scheithauer, Bernd W., Amrami, Kimberly K. , Wenger, Doris E. , Hébert-Blouin, Marie-Noëlle, Hébert‐Blouin, Marie‐Noëlle

Mayo Clinic

Journal of Neurosurgery | October 7, 2011 | Volume: 116 | Issue: 2 | Pages: 418-431

10.3171/2011.8.jns101292 | PMID 21981643 Get It

Object Adipose lesions of nerve are rare and poorly understood. Their current classification, although not universally accepted, generally includes lipomatosis of nerve with or without localized macrodactyly, and intra- as well as extraneural lipoma. The authors believe that the spectrum of these lesions and their interrelationships are not currently appreciated. They propose an adaptation to the existing framework to illustrate the expanding spectrum of adipose lesions of nerve by considering lipomatosis and lipoma singly or in combination. Methods Fourteen representative cases are presented to demonstrate not only the intraneural and extraneural examples of lipomatosis and lipoma, but also their anatomical combinations. Results Based on the cases presented and a careful literature review, a conceptual approach to the classification of adipose lesions of nerve is generated. This approach incorporates the 2 essential lesions, lipomatosis of nerve and lipoma, in both their intra- and extraneural forms. This permits expansion to encompass combinations. Conclusions To press the concept that adipose tumors of nerve are a broad but interrelated spectrum of lesions, the authors propose modification of the present classification system. This approach provides an orderly platform for progress, reflects understanding of these interrelated lesions, and facilitates optimal treatment by distinguishing resectable from nonresectable components.
Fibromatosis: a potential sequela of neuromuscular choristoma
Hébert-Blouin, Marie-Noëlle, Scheithauer, Bernd W., Amrami, Kimberly K. , Durham, Susan, Spinner, Robert J. , Hébert‐Blouin, Marie‐Noëlle

Mayo Clinic

Journal of Neurosurgery | August 5, 2011 | Volume: 116 | Issue: 2 | Pages: 399-408

10.3171/2011.6.jns102171 | PMID 21819193 Get It

Object Neuromuscular choristoma (NMC) is a rare peripheral nerve lesion in which mature skeletal muscle fibers lie within the nerve and its fascicles. Given limited follow-up, its natural history is poorly understood. The occurrence of aggressive fibromatosis in one of the authors' patients and its occurrence in reported cases suggests an etiological relationship between the 2 lesions. This study attempts to explain the association and its frequency. Methods All cases of NMCs seen in consultation or treated at the Mayo Clinic were identified. Demographic and clinical data were reviewed in cases with coexistent aggressive fibromatosis. Pathology and neuroimaging studies were reexamined. In addition, an extensive literature review was performed to explore the association of NMC with aggressive fibromatosis, with special attention given to pathological and imaging characteristics and the development of aggressive fibromatosis. Results The authors identified 10 patients with a diagnosis of NMC who were treated at the Mayo Clinic between 1992 and 2010. Four of 5 with adequate follow-up had developed a definite or suspected aggressive fibromatosis. A review of the initial pathological specimens in these cases revealed no evidence of fibromatosis, but all of the lesions exhibited accompanying hypocellular collagenous tissue. On MR images, all cases showed areas of low signal intensity, which significantly differed from muscle, nerve, and NMC components. On available serial MR imaging studies, aggressive fibromatosis seemed to originate in such lower-intensity regions. In the 18 previously reported cases of NMC, 5 patients developed recurrent masses diagnosed as either definite (2 cases) or possible (3 cases) fibromatosis. Review of the published imaging studies in these cases suggests the presence of lower intensity areas similar to those observed in the 10 patients treated at the Mayo Clinic. Conclusions This study confirms that the development of aggressive fibromatosis in patients with NMC has been underreported. A direct relationship between the NMC and the development of aggressive fibromatosis is suggested by pathological and neuroimaging evidence.
Estrogen and Progesterone Receptors in Meningiomas: Comparison of Nuclear Binding, Dextran-Coated Charcoal, and Immunoperoxidase Staining Assays
Halper, Jaroslava , Colvard, Douglas S., Scheithauer, Bernd W., Jiang, Nai‐Siang, Graham, Mark L., Riehl, Elizabeth, Laws, Edward R. , Spelsberg, Thomas C., Press, Michael F.

Mayo Clinic

Neurosurgery | April 23, 2011 | Volume: 25 | Issue: 4 | Pages: 546-553

10.1227/00006123-198910000-00007 Get It

Abstract We studied the status of estrogen (ER) and progesterone (PR) receptors in meningiomas removed from 52 patients, comparing dextran-coated charcoal (DCC), nuclear binding (NB), and immunoperoxidase (IP) assays. Each of the assays was performed independently by investigators well-experienced with these assays. The NB assay is a new assay that measures functional steroid receptors—that is, the activation of the receptor and its binding to the nucleus. The assay is very sensitive and requires a relatively small amount of tissue as compared with the DCC assay. In agreement with data from other studies, PR were detected in most meningiomas by all 3 methods: in 69% of the cases by NB, in 76% by DCC, and in 89% by IP. ER were detected in only a few cases: in 33% by NB, in 2% by DCC, and in none by the IP assay. The agreement for PR sites was 62% for all 3 assays, it was 66% between the NB and DCC assays, 67% between the NB and IP assays, and 86% between the DCC and IP assays. Of 26 cases that were positive by the DCC assay, 6 (23%) were negative by NB. The overall agreement for all three ER assays was 65%. The data suggest that the majority of meningiomas contain high-affinity receptors for progesterone, that estrogen receptors are present in only a few meningiomas, and that some of these estrogen and progesterone receptors appear to be functional.
Pituitary Adenomas that Produce Adrenocorticotropic Hormone and A-Subunit: Clinicopathological, Immunohistochemical, Ultrastructural, and Immunoelectron Microscopic Studies in Nine Cases
Berg, Kathryn K., Scheithauer, Bernd W., Félix, Ignacio, Kovács, Kálmán, Horváth, Éva , Klee, George G., Laws, Edward R.

Mayo Clinic

Neurosurgery | April 23, 2011 | Volume: 26 | Issue: 3 | Pages: 397-403

10.1227/00006123-199003000-00004 Get It

Abstract Eight surgical and one autopsy specimen of pituitary adenomas (six cases of Cushing's disease, two of Nelson's syndrome. and one of hypopituitarism) were studied by histochemical, immunohistocytological, and ultrastructural methods. Eight tumors showed the characteristic histochemical profile of corticotroph adenoma—amphophilic to basophilic, and periodic acid-Schiff-positive to some extent. In all tumors, immunohistochemical studies revealed adrenocorticotropic hormone (ACTH) and à-subunit in the cytoplasm of some adenoma cells. By electron microscopy, seven tumors were found to be monomorphous; six were typical corticotroph adenomas and one was a subtype II silent corticotroph adenoma. One unique lesion was bimorphous—i.e., composed of corticotrophs as well as cells resembling glycoprotein cells. Immunoelectron microscopy by the double-labeling immunogold technique, performed on one corticotroph adenoma, demonstrated the presence of ACTH and à-subunit not only within the same adenoma cells but also within the same secretory granules. The cytogenesis of ACTH à-subunit tumors, a rare form of plurihormonal adenoma. remains to be elucidated. The duration of disease associated with these tumors exceeded the duration in patients with ordinary corticotroph adenomas. Given the low frequency with which increases in serum à-subunit are detectable in patients with such tumors—13% in this series—hormone production is not recognized at preoperative evaluation.
Intracranial Fibromatosis
Mitchell, Andrew , Scheithauer, Bernd W., Ebersold, Michael J., Forbes, Glenn S.

Mayo Clinic

Neurosurgery | April 23, 2011 | Volume: 29 | Issue: 1 | Pages: 123-126

10.1227/00006123-199107000-00022 Get It

Abstract Fibromatoses are uncommon infiltrative lesions affecting musculoaponeurotic structures, most often of the limbs and trunk. Lesions involving the cranial cavity are rare and require the same aggressive surgical management as elsewhere in the body. This case illustrates their clinical and neuroradiological features and underscores the necessity for aggressive resection to avoid recurrence. The literature is reviewed. (Neurosurgery 29:123-126, 1991)
Subependymoma with Rhabdomyosarcomatous Differentiation: Report of a Case and Literature Review
Tomlinson, Frank H., Scheithauer, Bernd W., Forbes, Glenn S. , Kelly, Patrick J. A.

Mayo Clinic

Neurosurgery | April 23, 2011 | Volume: 28 | Issue: 5 | Pages: 761-768

10.1227/00006123-199105000-00024 Get It

Abstract A unique gliomesenchymal neoplasm, consisting of a subependymoma, a form of low-grade glioma, and a rhabdomyosarcoma, is described. It arose and recurred in the brain stem of a 52-year-old man. Immunohistochemical studies demonstrated the presence of a neuroectodermal marker S-100 protein within some sarcoma cells. The occurrence of this rare tumor supports the concept that striated muscle may derive from a neuroectodermal precursor lesion.